Complaints Outcomes

Search

Search Results

Search Again
Pharmacist Registrant 27 (Feb 23, 2021)
 

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended for an indefinite period on August 27, 2020. Pursuant to Section 32.2(4)(b)(i) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the pharmacist registrant consented to terms including, but not limited to, the following:

  1. To comply with any and all recommendations and treatment prescribed or directed by medical professionals involved in the Registrant's care;

  2. To comply with any and all work plans and gradual return to work protocols as advised by the Registrant’s medical professionals and/or employers;

  3. To strictly adhere to the Registrant's routine medical monitoring program for a total period of 5 years of monitoring;
     
  4. To not order, handle, prepare, dispense or destroy any narcotic, controlled or targeted substances the Registrant may have access to while being medically monitored;
     
  5. To inform the College in via e-mail of the Registrant’s places of employment as a pharmacist and report any changes to the location of their employment within 48 hours of such change;
     
  6. To inform all managers and employers with whom the Registrant gains employment of the limits and conditions on registration pursuant to the Agreement, if the pharmacy dispenses mood altering drugs;
     
  7. To ensure that all managers and employers with whom the Registrant gains employment submits a written statement to the College declaring their awareness of the limits and conditions on registration pursuant to the Agreement, if the pharmacy dispenses mood altering drugs;

The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.


August 27, 2020
(February 23, 2021 - Registration Reinstated)

 

The Inquiry Committee, pursuant to section 32.2(4)(b)(ii) of the Health Professions Act, has reached an agreement with the pharmacist registrant to voluntarily suspend the registration as a pharmacist effective August 27, 2020. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.


February 11, 2020
(August 27, 2020 - REGISTRATION Suspended)

 

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended for an indefinite period on May 12, 2019. Pursuant to Section 32.2(4)(b)(i) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the pharmacist registrant consented to terms including, but not limited to, the following:

  1. To comply with any and all recommendations and treatment prescribed or directed by medical professionals involved in the Registrant's care;
     
  2. To comply with any and all work plans and gradual return to work protocols as advised by the Registrant’s medical professionals and/or employers;
     
  3. To strictly adhere to the Registrant's routine medical monitoring program for the current 3 year period, and then sign an identical agreement for monitoring for an additional 2 years, for a total period of 5 years of monitoring;
     
  4. To not order, handle, prepare, dispense or destroy any narcotic, controlled or targeted substances the Registrant may have access to while being medically monitored;
     
  5. To inform the College in via e-mail of the Registrant’s places of employment as a pharmacist and report any changes to the location of their employment within 48 hours of such change;
     
  6. To inform all managers and employers with whom the Registrant gains employment of the limits and conditions on registration pursuant to the Agreement, if the pharmacy dispenses mood altering drugs;
     
  7. To ensure that all managers and employers with whom the Registrant gains employment submits a written statement to the College declaring their awareness of the limits and conditions on registration pursuant to the Agreement, if the pharmacy dispenses mood altering drugs.

May 12, 2019
(FEBRUARY 11, 2020 - REGISTRATION REINSTATED)

The Inquiry Committee, pursuant to section 32.2(4)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend the registration as a pharmacist effective May 12, 2019. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.


November 7, 2016

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended for an indefinite period on June 10, 2016. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4) of the Health Professions Act


June 10, 2016
(NOVEMBER 7, 2016 – REGISTRATION REINSTATED)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend the registration as a pharmacist effective June 10, 2016. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to section 39.3(4) of the Health Professions Act.

Pharmacist Registrant 22 (Feb 21, 2021)

The Inquiry Committee has approved an amendment to the November 5, 2020 Consent Agreement. The pharmacist registrant is no longer restricted from acting as a preceptor.


November 5, 2020
(February 21, 2021 - Limits and conditions updated)

The Inquiry Committee pursuant to section 36(1) of the Health Professions Act and after consultation with the pharmacist registrant’s physician, has reached an Agreement with the pharmacist registrant to amend some of the terms in the Agreement of June 5, 2019. The pharmacist registrant is now being medically monitored by a different medical provider.


October 22, 2019
(November 5, 2020 - Limits and conditions updated)

The Inquiry Committee has approved an amendment to the June 5, 2019 Consent Agreement. The pharmacist registrant is no longer restricted from being a manager of a pharmacy.


JunE 5, 2019
(October 22, 2019 - LIMITS AND CONDITIONS UPDATED)

The Inquiry Committee, pursuant to section 36(1) of the Health Professions Act and after consultation with the pharmacist registrant’s physician, has reached an Agreement with the pharmacist registrant to amend some of the terms in the Agreement of October 12, 2018. The Registrant can now:

  • work alone in a pharmacy;
  • handle, physically prepare, and dispense prescriptions for opioid medications;
  • have access to the narcotic safe;
  • be involved with ordering narcotic medications.

October 12, 2018
(June 5, 2019 - Limits and Conditions Updated)

The Inquiry Committee has reinstated the pharmacist registrant’s registration which had previously been suspended for an indefinite period on August 13, 2015. Pursuant to Section 36(1) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the pharmacist registrant consented to terms including, but not limited to, the following:

  1. To strictly adhere to the Registrant's routine medical monitoring program with the institution currently involved in the Registrant's care and remaining on the monitoring program for a period of at least 3 years;

  2. To comply with any and all recommendations and treatment prescribed or directed by medical professionals involved in the Registrant's care;

  3. To not work alone in a pharmacy, and to have another pharmacist in good standing supervising the Registrant at all times;

  4. To not handle, physically prepare, or dispense prescriptions for opioid medications at any time;

  5. To not have any access whatsoever, on or off duty, to the narcotic safe in any pharmacy;

  6. To not be involved in any way with ordering narcotic medications, except for signing off on the necessary paperwork in the presence of a witnessing pharmacy staff member for the purposes of receiving and stocking such narcotics;

  7. To inform all managers and employers with whom the Registrant gains employment of his medical condition and the limits and conditions on registration pursuant to the Agreement;

  8. To ensure that all managers and employers with whom the Registrant gains employment submits a written statement to the College declaring their awareness of the Registrant's medical condition and the Agreement, and how they will accommodate and supervise the Registrant working in the pharmacy;
     
  9. To inform the College in via e-mail of his places of employment as a pharmacist and report any changes to the location of his employment within 48 hours of such change; and

  10. To be restricted from acting in the following roles in the Registrant's practice:

    1. Be a manager of a pharmacy;
    2. Be an owner (direct or indirect) of a pharmacy; and
    3. Act as a preceptor.

     


August 13, 2015
(October 12, 2018 – Registration Reinstated)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with the pharmacist registrant to suspend registration as a pharmacist effective August 13, 2015. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.


February 13, 2015
(AUGUST 13, 2015 - Registration Suspended)

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended for an indefinite period on August 5, 2014. Pursuant to section 36 of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the Registrant consented to undertakings involving regular monitoring for fitness to practice pharmacy. The undertakings include, but are not limited to:

  1. Routine and random medical monitoring;

  2. Informing all managers and employers with whom Registrant gains employment of Registrant’s medical condition and the limits and conditions on Registrant’s registration pursuant to the agreement;

  3. Ensuring that all managers and employers with whom Registrant gains employment submits a written statement to the College declaring their awareness of Registrant’s medical condition and the agreement, and how they will accommodate and supervise Registrant working in pharmacy;

  4. Registrant will not work alone in a pharmacy setting, meaning that Registrant must never be the sole pharmacist in attendance at any time and that there must be another pharmacist or pharmacy assistant or pharmacy staff working with Registrant at all times;

  5. Registrant will not have access to narcotic-safe or physically process and/or otherwise prepare any prescriptions that require access to the narcotic safe;

  6. Registrant will not be involved in any way with ordering supplies of narcotic medications;

  7. Registrant will not be involved in the dispensing, ordering, contact, destruction, counting or otherwise handling of opiate medications and other medications with abusive potential;

  8. Being restricted from the following roles in Registrant’s practice:

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor.

     

  9. Notifying the College of:

    1. all changes in places of employment as a pharmacist
    2. all changes in residential address and phone number; and
    3. all changes in medical provider.

     

The Agreement will remain in place for a minimum of three years of continuous pharmacy practice. The name of the Registrant has been withheld in accordance with section 39.3(4)(a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public. 


August 5, 2014
(February 13, 2015 – Registration reinstated)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with the pharmacist registrant to suspend registration as a pharmacist effective August 5, 2014. The Agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Serjeant, Rina (Jan 7, 2021)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of now former registrant Rina Serjeant (the “Former Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

    The Inquiry Committee and the Former Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: January 7, 2021

  3. Name of registrant: Rina Serjeant

  4. Location of Practice: N/A

  5. Admissions and Acknowledgements:

    Multiple registrants were involved in this matter.

    The College’s investigation found that between January 2012 and June 2018, over 20,000 false transactions were processed on patient PharmaNet records at two pharmacies, where the Registrant had worked as a pharmacy manager at one of the pharmacies. These transactions were considered false because:

    • Schedule I (prescription) medications associated with these transactions had not been authorized or prescribed by the prescriber associated with each transaction;
    • Medications associated with these transactions, which included Schedule I, Over-The-Counter (“OTC) medications and vitamins, were not actually dispensed to the “patient” in each case;
    • Transactions were processed as one-day supplies or seven-day supplies, for the sole purpose of artificially inflating prescription counts; and
    • Transactions were processed not for the purpose of providing health care and were not processed with each patient’s voluntary consent.


    The College’s investigation also found that during the same time period, over 10,000 transactions were processed on patient PharmaNet records for medications that were actually authorized but processed as one-day supplies or seven-day supplies when there was no clinical indication to do so. The medications for these transactions were not actually dispensed to the patient on a daily or weekly basis, making each patient’s PharmaNet records inaccurate and not current. These transactions were processed in this manner for the sole purpose of artificially inflating prescription counts.

    The “patients” whose PharmaNet records were affected were all either current or former employees of the two pharmacies, or family members of former employees of the two pharmacies. Reportedly, the owner of the two pharmacies had directed for transactions to be processed in the above manner in order to artificially inflate prescription counts at both pharmacies.

  6. The Registrant's Involvement and Acknowledgements:

    Regarding the Former Registrant’s involvement in this matter, the Inquiry Committee considered it substantiated, and the Former Registrant has acknowledged, that:

    1. On the PharmaNet record of her colleague, her name was associated with false PharmaNet transactions for vitamins and supplements, as the “prescriber” of these vitamins and supplements. The Former Registrant’s signature was on the prescription hardcopies of these transactions, meaning that she had checked these prescriptions before the hardcopies had been filed away;

    2. The majority of these transactions had been backdated, meaning that the transaction records were created on a date later than the date that appears on PharmaNet. The Former Registrant’s signature appeared on the prescription hardcopies of the backdated transactions, meaning that she knew, or ought to have known, that the transactions had been backdated;

    3. She processed medications on PharmaNet for herself;

    4. She enabled the inappropriate use of personal health information and the creation of inaccurate PharmaNet records, placing her colleague at risk of harm, in case their PharmaNet record ever needed to be accessed for legitimate medical reasons;

    5. She failed to report to the College or to another person of authority regarding the improper practices occurring at the pharmacy, even though she knew that these practices were improper; and

    6. As pharmacy manager, she enabled the false transactions on patient PharmaNet records, did not set or enforce policies and procedures at the pharmacy to ensure compliance with practice standards, and did not actively participate in the day-to-day management of the pharmacy.

  7. Disposition

    The Former Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms (in part):

    1. To pay a $3000.00 fine;
       
    2. To have a letter of reprimand placed permanently on the College register;
       
    3. If she reinstates her registration to Full Pharmacist status, upon reinstatement:
       
      1. To successfully complete and pass an ethics course for healthcare professionals within two years. If she fails to complete this within the specified time period, her registration will be suspended for a period of 60 days;
         
      2. To appear before the Inquiry Committee for a verbal reprimand;
         
      3. To not be a pharmacy manager and/or a preceptor for pharmacy students for a period of 2 years;
         
      4. To successfully pass the College’s Jurisprudence Exam; and
         
      5. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association.
         
  8. Rationale:

    The Former Registrant’s actions were considered serious contraventions of legislation involving pharmacy practice standards, the appropriate access, use and protection of personal health information and PharmaNet records, and her role as a pharmacy manager. Her misconduct placed others at risk of harm. The Former Registrant also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, committing to personal and professional integrity, participating in ethical business practices, and conflicts of interest.

    In determining an appropriate disposition for the Former Registrant, the Inquiry Committee considered the Former Registrant’s report of feeling pressured by her employer (the pharmacy owner) to commit these actions, and that she personally did not stand to gain financially from what occurred.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access and use of personal health information compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to appropriately access, use and protect personal health information.

Drenic-Stojanovic, Drena (Dec 30, 2020)

Nature of Action: Pursuant to section 35(1)(a) of the Health Professions Act, R.S.B.C. 1996, c. 183 (“HPA”), effective December 30, 2020, the Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) has made an order to impose limits and conditions on the pharmacy practice of the registrant Drena Drenic-Stojanovic (the “Registrant”) during the investigation into the Registrant’s practice, as follows:

  1. The Registrant shall not be involved in any way in the preparation, compounding, manipulation and/or dispensing of injectable and/or sterile products to patients/clients or health care providers/prescribers for office use;
  2. The Registrant shall not act as a pharmacy manager or owner;
  3. The Registrant shall not act as a preceptor to students or be responsible for the supervision of other staff and/or registrants;
  4. The Registrant must work under the direct supervision of another registrant acceptable to College staff; and
  5. The Registrant must inform any employer of these limits and conditions of her practice and provide it with a copy of this decision.

The Inquiry Committee considered this action necessary to protect the public.

Reasons: While practising as a pharmacist, it is alleged that the Registrant did not comply with the applicable legislation and standards of practice required to compound sterile preparations. While practising as a pharmacist, it is alleged that the Registrant distributed compounded sterile preparations from an unlicensed pharmacy.

Note: Limits and conditions ordered by the Inquiry Committee under section 35(1)(a) of the HPA are made to protect the public during an investigation or pending a hearing of the Discipline Committee. Orders made under this section relate to matters which are and remain unproven unless admitted by a registrant or determined by the Discipline Committee.

Pharmacist Registrant 45 (Dec 23, 2020)

The Inquiry Committee has reinstated pharmacist registrant’s registration, which had previously been suspended for an indefinite period on October 20, 2020. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4) of the Health Professions Act


October 20, 2020
(December 23, 2020 - Registration Reinstated)

The Inquiry Committee, pursuant to section 32.2(4)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend their registration as a pharmacist effective October 20, 2020. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Amara, Alaa Mohssen (Dec 18, 2020)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (“CPBC”) conducted an investigation into the practice of Alaa Mohssen Amara (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183 (“HPA”). The CPBC issued a Citation on July 6, 2020, which was subsequently amended on November 23, 2020.

    Further to a proposal for resolution from the Registrant, the Inquiry Committee made a Consent Order under section 37.1 of the HPA.

  2. Effective date: December 18, 2020

  3. Name of registrant: Alaa Mohssen Amara

  4. Location of Practice: Powell River, BC

  5. Admissions and Acknowledgements: The Registrant has admitted and/or acknowledged the following (in part):

    1. In or about February 2018, the Registrant allowed a pharmacy opioid agonist treatment (“OAT”) patient to deliver methadone to a medical clinic for administration to another pharmacy OAT patient.

    2. The Registrant failed to ensure the security of methadone by allowing it to be delivered to a medical clinic without taking sufficient precautions to ensure a secure chain of custody.

    3. The Registrant misled a College investigator and the Inquiry Committee during the investigation by not providing accurate and truthful information regarding non-pharmacist methadone delivery.

    4. Between December 2017 and February 2018, on multiple occasions, the Registrant dispensed a patient’s methadone contrary to the prescription in terms of quantity dispensed.

    5. The Registrant caused or allowed multiple methadone maintenance treatment (“MMT”) prescriptions for an OAT patient to be dispensed contrary to the legislation and practice standards.

    6. The Registrant failed to ensure that the required documentation was completed and/or retained for an OAT patient, including documentation for deliveries completed, physician notifications for missed doses, and part-fill accountability logs.

    7. From about July 1, 2017 until March 27, 2018, on multiple occasions, the Registrant backdated methadone prescriptions and failed to review the patient’s personal health information on PharmaNet prior to dispensing MMT.

    8. During a college pharmacy inspection:

      1. The Registrant was only able to produce one narcotic reconciliation. The Registrant failed to ensure that adequate narcotic counts and reconciliations were completed for the pharmacy.

      2. Schedule I, II, and III drugs and controlled drug substances were unsecured. The Registrant failed to ensure appropriate security and storage of all Schedule I, II, and III drugs and controlled substances.

    9. The Registrant failed to reverse information in the PharmaNet database for several drugs not released to a patient or the patient’s representative, and the Registrant failed to record the reason for the reversal no later than 30 days from the date of the original entry of the prescription information in PharmaNet.

    10. The Registrant was engaged in a conflict of interest and unethical behaviour by allowing OAT patients to work in the pharmacy.

    11. The Registrant breached his undertakings made to the Inquiry Committee on July 17, 2012 and February 11, 2015.

  6. Disposition:

    In the Consent Order under section 37.1 of the HPA, the Inquiry Committee ordered that the Registrant (in part):

    1. Pursuant to section 39(2) of the HPA, the Registrant’s registration with the CPBC is suspended for a period of 90 days commencing April 1, 2021 to June 29, 2021;

    2. Will not be a manager for a period of 90 days commencing on the date his suspension ends (June 30, 2021 to September 27, 2021);

    3. Successfully complete and pass the CPEP PROBE “Ethics and Boundaries Program”. After the successful completion of the program, to meet with the Inquiry Committee to reflect on his conduct and what he has learned from the program;

    4. Consent to a letter of reprimand; 

    5. Will not be a preceptor of pharmacy students and/or international pharmacy graduates for a period of five (5) years commencing on December 16, 2020 to December 15, 2025; and

    6. Pay a fine of $5000 to the CPBC.

  7. Rationale:

    The Registrant contravened sections of the HPA, Pharmacy Operations and Drug Scheduling Act (“PODSA”) Bylaws, HPA Bylaws, and the Code of Ethics in his practice as a pharmacist, pharmacy manager, owner and director, and thereby, neglected his basic duties as a pharmacist, and committed or allowed actions that were unethical and could potentially endanger patient health. The totality of his conduct demonstrated a breach of trust and undermines the integrity of the profession.

    The Registrant’s conduct in this instance, coupled with the breach of his previous undertakings, is considered professional misconduct and justifies serious consequences. The Inquiry Committee considered it appropriate that the disposition for such conduct be one that serves as a strong deterrent and sends a clear message to both the profession and the public that the CPBC does not tolerate this type of conduct under any circumstances.

Pharmacist Registrant 48 (Dec 18, 2020)

The Inquiry Committee, pursuant to section 32.2(4)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend their registration as a pharmacist effective December 18, 2020. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Pharmacist Registrant 46 (Nov 20, 2020)

The Inquiry Committee, pursuant to section 32.2(4)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend their registration as a pharmacist effective November 20, 2020. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Liu, Hongwei (Liuna) (Oct 26, 2020)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (“College”) conducted an investigation into the practice of Hongwei Liu (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

    The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: October 26, 2020

  3. Name of registrant: Hongwei (Liuna) Liu

  4. Location of Practice: Surrey, BC

  5. Admissions and Acknowledgements: 

    The Registrant has admitted and/or acknowledged the following:

    1. Between January 2019 and September 2019, as pharmacy manager:

      1. The Registrant and other pharmacy staff dispensed prescriptions to two patients for a quantity of seven days but processed those prescriptions once daily onto PharmaNet. This practice resulted in inadequate prescription preparation, inaccurate clinical assessments, incomplete PharmaNet checks, and false final checks, thereby breaching sections 2, 6, and 9.1 of the Health Professions Act, Bylaws, Schedule F, Part 1 – Community Pharmacy Standards of Practice (“Standards of Practice”).

      2. The Registrant and other pharmacy staff did not provide pharmacist/patient consultations for the patients involved in this matter, contrary to section 12 of the Standards of Practice.

      3. The Registrant did not maintain current PharmaNet records for the patients involved in this matter, contrary to section 35(1) of the Pharmacy Operations and Drug Scheduling Act, Bylaws.

    2. The Registrant was responsible for the overall management of the pharmacy’s practices.

    3. The Registrant provided misleading information during the investigation into the matter, including not providing truthful or accurate information.

  6. Disposition:

    The Registrant entered into a Consent Agreement with the Inquiry Committee, wherein the Registrant consented to the following terms (in part):

    1. To not be a pharmacy manager for a period of six months;

    2. To pay a $7,500.00 fine;

    3. To successfully pass the College’s Jurisprudence Exam;

    4. To successfully complete and pass an ethics course for healthcare professionals; and

    5. To have a Letter of Reprimand placed on her registration record for a period of five years.

  7. Rationale:

    The Inquiry Committee considered, that as the pharmacy’s manager, the Registrant was responsible to ensure that the pharmacy practiced pursuant to the applicable legislation and standards of pharmacy practice. As pharmacy manager, the Registrant played a significant role in allowing for false transactions to be processed onto PharmaNet, thereby creating inaccurate PharmaNet records. Additionally, the Inquiry Committee considered that during the investigation into the matter, the Registrant provided false and misleading information.

    The Inquiry Committee determined that the volume of practice deficiencies required a serious response to bring Registrant’s practice into compliance with the standards of pharmacy practice and that the dispositions were warranted as it addressed the seriousness of the Registrant’s failure to adhere to principles and standards expected of registrants, especially when taking on roles such as pharmacy manager.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. 

Thiara, Kuljeet Singh (Oct 19, 2020)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (“College”) conducted an investigation into the practice of Kuljeet Singh Thiara (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

    The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: October 19, 2020

  3. Name of registrant: Kuljeet Singh Thiara

  4. Location of Practice: Abbotsford, BC

  5. Admissions and Acknowledgements: 

    The Registrant has admitted and/or acknowledged the following:

    1. As a pharmacy manager, the Registrant was responsible, pursuant to section 18(2)(b) of Pharmacy Operations and Drug Scheduling Act Bylaws, for ensuring compliance with all legislation, bylaws, policies and procedures applicable to the operation of a pharmacy.

    2. On January 30, 2020, at the pharmacy where the Registrant had been manager, pharmacy staff incorrectly identified a patient and dispensed incorrect prescriptions.

      The incident was the fourth time in a period of fourteen months, and the sixth time that the Registrant’s practice as a pharmacy manager was the subject of an Inquiry Committee matter. The Registrant had previously signed Consent Agreements to remediate similar practice concerns. For these Consent Agreements, he had consented to undertakings to take steps to prevent recurrences of similar incidents.

  6. The Registrant's involvement and acknowledgments:

    The Registrant entered into a Consent Agreement with the Inquiry Committee of College, wherein the Registrant consented to the following terms (in part):

    1. To not act as a pharmacy manager for a period of one (1) year from October 19, 2020 to October 19, 2021. Prior to applying to act in the role of a pharmacy manager, he must successfully complete the BC Community Pharmacy Manager Training Program provided by the British Columbia Pharmacy Association.

    2. To pay a $7,500.00 fine.

  7. Rationale:

    The Inquiry Committee determined that on multiple instances, the Registrant failed to comply with terms of his previous Consent Agreements and there had been recurring incidents of similar nature. On multiple instances, the Registrant failed to meet his legislative responsibilities as a pharmacy manager pursuant to the Pharmacy Operations and Drug Scheduling Act Bylaws.

    The Inquiry Committee determined that the Registrant required serious remediation and deterrence in order to come into compliance with his responsibilities as a pharmacy manager. The Inquiry Committee considered the terms of the Consent Agreement appropriate to protect the public and resolve the matter.

Pages